Novavaxhas received positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) forfull marketing authorisation (MA) of its Covid vaccine, Nuvaxovid (NVX-CoV2373), in the European Union (EU). A protein-based vaccine, Nuvaxovid has been recomme...
It marks a step towards full regulatory endorsement in the European region. This is the first pivotal trial for the disease to report improvements in histologic outcomes, aligning with the European Crohn’s and Colitis Organisation’s (ECCO) statement on mucosal histopathology. How well do youreall...
Enzalutamide is a novel, once-daily, oral androgen receptor signalling inhibitor. 2 It inhibits multiple steps in the androgen receptor (AR) signalling pathway, which has been shown to decrease cancer cell growth and can induce cancer cell death (apoptosis). 2 The...
CHMP recommends heart failure drug Entresto